Contactless Measurement of Heart Rate, Heart Rate Variability, Breathing Rate and Blood Pressure Using Remote Photoplethysmography

NCT ID: NCT06829615

Last Updated: 2025-11-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

132 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-05-06

Study Completion Date

2025-10-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study it to evaluate the accuracy of heart rate, heart rate variability, breathing rate and blood pressure measurement with the use of Shen.AI software.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The primary objective of this clinical study is to assess the accuracy of heart rate (HR), heart rate variability (HRV), breathing rate (BR), and blood pressure (BP) measurements obtained using Shen.AI software as the investigational device under its intended conditions of use, enabling users to obtain reliable information about their physiological state. These conditions include measurements taken at rest, in a home-like environment, with participants independently operating a mobile device or laptop equipped with a camera.

Physiological parameters, including HR, HRV, BR, and BP, will be measured and estimated using remote photoplethysmography (rPPG) based on a 1-minute facial video analysis processed by Shen.AI software.

Throughout all measurements, participants will be connected to a reference device that records ECG while simultaneously measuring chest impedance (impedance pneumography). Additionally, each participant will wear a respiratory belt transducer. Depending on the measurement type, the participant's blood pressure will be assessed using either an auscultatory or an automatic blood pressure monitor. The study will be conducted on a diverse group of participants, varying in blood pressure, gender, age, skin phototype, and BMI.

For each measured parameter, results obtained from both methods will be compared using Bland-Altman analysis or non-parametric limits of agreement.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Rate Heart Rate Variability Breathing Rate Blood Pressure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

HR, HRV, BR, and BP measured using Shen.AI and reference methods

Group Type EXPERIMENTAL

Shen.AI

Intervention Type DEVICE

Contactless measurement of heart rate, heart rate variability, breathing rate, and blood pressure using Shen.AI software and reference methods.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Shen.AI

Contactless measurement of heart rate, heart rate variability, breathing rate, and blood pressure using Shen.AI software and reference methods.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 18 years
* Ability to read and write in Polish or English
* Ability to operate a mobile device and a laptop without requiring glasses
* Ability to understand the study procedure
* Ability to communicate and follow instructions from the study personnel
* Provision of written informed consent for participation in the study and for the processing of personal data by the research team and the study sponsor
* Blood pressure values in accordance with the distribution of the study group

Exclusion Criteria

* Pregnancy
* Age below 18 years
* Failure to provide the required information in the participant's informational questionnaire
* Non-compliance with the study procedure or instructions from the study personnel
* Extensive facial skin damage (e.g., abrasions, wounds, burns)
* A disease process affecting a significant portion of the face
* Extensive facial dressing
* Extensive facial tattoos or facial painting
* Significant facial deformity (e.g., tumor)
* Inability to maintain a stable head position during measurement
* Persistent cough preventing stillness during measurement
* Respiratory dysfunction such as dyspnea, irregular or shallow breathing
* Diagnosed arrhythmia (except for sinus bradycardia or sinus tachycardia)
* Moderate or severe anemia
* Diagnosed conditions such as left ventricular systolic dysfunction, aortic valve stenosis, or other cardiac or circulatory diseases leading to low stroke volume, low pulse amplitude, or pulsus paradoxus
* Implanted cardiac pacemaker
* Blood pressure difference between arms exceeding 15 mmHg for systolic pressure or 10 mmHg for diastolic pressure
* Inability to determine blood pressure in both arms
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

SHEN.AI spółka z ograniczoną odpowiedzialnością oddział w Polsce

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Justyna Chojdak-Łukasiewicz, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Wroclaw Medical University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

OVO MEDICAL Sp. z o.o.

Wroclaw, Lower Silesian Voivodeship, Poland

Site Status

Przychodnia rehabilitacyjna R-MED

Wroclaw, Lower Silesian Voivodeship, Poland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Poland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MDF-01-008-03

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.